{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:46:09Z","timestamp":1789469169233,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21OC0071847"],"award-info":[{"award-number":["NNF21OC0071847"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF19OC0055353"],"award-info":[{"award-number":["NNF19OC0055353"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"University of Southern Denmark","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09565-y","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:55:04Z","timestamp":1772614504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Repairing Peri-Anal Fistulas with regenerative cell therapeutics: study protocol for a double-blinded randomized controlled phase I\u2013II trial from Denmark (REP-PAF)"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3330-8525","authenticated-orcid":false,"given":"Karam Matlub","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Harken","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Qvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte Caroline","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Ahm","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"2-3","key":"9565_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1445-2197.1997.tb01911.x","volume":"67","author":"N Barwood","year":"1997","unstructured":"Barwood N, Clarke G, Levitt S, Levitt M. Fistula-in-ano: a prospective study of 107 patients. Aust N Z J Surg. 1997;67(2\u20133):98\u2013102.","journal-title":"Aust N Z J Surg"},{"issue":"11","key":"9565_CR2","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1097\/DCR.0000000000001800","volume":"64","author":"MD Aguilar-Martinez","year":"2021","unstructured":"Aguilar-Martinez MD, Sanchez-Guillen L, Barber-Valles X, Alcaide-Quiros MJ, Bosch-Ramirez M, Lopez-Delgado A, et al. Long-term evaluation of fistulotomy and immediate sphincteroplasty as a treatment for complex anal fistula. Dis Colon Rectum. 2021;64(11):1374\u201384.","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"9565_CR3","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1007\/DCR.0b013e3181a80e24","volume":"52","author":"JV Roig","year":"2009","unstructured":"Roig JV, Jordan J, Garcia-Armengol J, Esclapez P, Solana A. Changes in anorectal morphologic and functional parameters after fistula-in-ano surgery. Dis Colon Rectum. 2009;52(8):1462\u20139.","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"9565_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00384-018-3042-6","volume":"33","author":"S Seyfried","year":"2018","unstructured":"Seyfried S, Bussen D, Joos A, Galata C, Weiss C, Herold A. Fistulectomy with primary sphincter reconstruction. Int J Colorectal Dis. 2018;33(7):911\u20138.","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"9565_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/DCR.0000000000000352","volume":"58","author":"AP Visscher","year":"2015","unstructured":"Visscher AP, Schuur D, Roos R, Van der Mijnsbrugge GJ, Meijerink WJ, Felt-Bersma RJ. Long-term follow-up after surgery for simple and complex cryptoglandular fistulas: fecal incontinence and impact on quality of life. Dis Colon Rectum. 2015;58(5):533\u20139.","journal-title":"Dis Colon Rectum"},{"key":"9565_CR6","doi-asserted-by":"crossref","unstructured":"Zimmerman DD, Mitalas LE, Schouten WR. Long-term functional outcome and risk factors for recurrence after surgical treatment for low and high perianal fistulas of cryptoglandular origin. Dis Colon Rectum. 2009;52(6):1196\u20137; author reply 7.","DOI":"10.1007\/DCR.0b013e3181a51354"},{"key":"9565_CR7","doi-asserted-by":"publisher","unstructured":"Sipp D, Caulfield T, Kaye J, Barfoot J, Blackburn C, Chan S, et al. Marketing of unproven stem cell-based interventions: A call to action. Sci Transl Med. 2017;9(397):1946\u20136234. https:\/\/doi.org\/10.1126\/scitranslmed.aag0426.","DOI":"10.1126\/scitranslmed.aag0426"},{"issue":"3","key":"9565_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","volume":"28","author":"F de la Portilla","year":"2013","unstructured":"de la Portilla F, Alba F, Garcia-Olmo D, Herrerias JM, Gonzalez FX, Galindo A. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn\u2019s disease: results from a multicenter phase I\/IIa clinical trial. Int J Colorectal Dis. 2013;28(3):313\u201323.","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"9565_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00384-011-1350-1","volume":"27","author":"H Guadalajara","year":"2012","unstructured":"Guadalajara H, Herreros D, De-La-Quintana P, Trebol J, Garcia-Arranz M, Garcia-Olmo D. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis. 2012;27(5):595\u2013600.","journal-title":"Int J Colorectal Dis"},{"issue":"7","key":"9565_CR10","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/DCR.0b013e318255364a","volume":"55","author":"MD Herreros","year":"2012","unstructured":"Herreros MD, Garcia-Arranz M, Guadalajara H, De-La-Quintana P, Garcia-Olmo D, Group FC. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: Fistula Advanced Therapy Trial 1) and long-term evaluation. Dis Colon Rectum. 2012;55(7):762\u201372.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"9565_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/codi.13223","volume":"18","author":"KJ Park","year":"2016","unstructured":"Park KJ, Ryoo SB, Kim JS, Kim TI, Baik SH, Kim HJ, et al. Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn\u2019s disease: a pilot clinical trial. Colorectal Dis. 2016;18(5):468\u201376.","journal-title":"Colorectal Dis"},{"key":"9565_CR12","doi-asserted-by":"crossref","unstructured":"Dige A, Hougaard HT, Agnholt J, Pedersen BG, Tencerova M, Kassem M, et al. Efficacy of injection of freshly collected autologous adipose tissue into perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology. 2019;156(8):2208\u201316 e1.","DOI":"10.1053\/j.gastro.2019.02.005"},{"issue":"2","key":"9565_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ibd\/izz051","volume":"26","author":"S Laureti","year":"2020","unstructured":"Laureti S, Gionchetti P, Cappelli A, Vittori L, Contedini F, Rizzello F, et al. Refractory complex Crohn\u2019s perianal fistulas: a role for autologous microfragmented adipose tissue injection. Inflamm Bowel Dis. 2020;26(2):321\u201330.","journal-title":"Inflamm Bowel Dis"},{"key":"9565_CR14","doi-asserted-by":"crossref","unstructured":"Sorensen KM, Jensen CH, Sheikh SP, Qvist N, Sorensen JA. Treatment of fistulizing perianal Crohn\u2019s disease by autologous microfat enriched with adipose-derived regenerative cells. Inflamm Bowel Dis. 2021.","DOI":"10.1093\/ibd\/izab276"},{"issue":"8","key":"9565_CR15","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1053\/j.gastro.2019.01.032","volume":"156","author":"M Serrero","year":"2019","unstructured":"Serrero M, Grimaud F, Philandrianos C, Visee C, Sabatier F, Grimaud JC. Long-term safety and efficacy of local microinjection combining autologous microfat and adipose-derived stromal vascular fraction for the treatment of refractory perianal fistula in Crohn\u2019s disease. Gastroenterology. 2019;156(8):2335\u20137.","journal-title":"Gastroenterology"},{"issue":"4","key":"9565_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851\u20138.","journal-title":"Stem Cells"},{"key":"9565_CR17","doi-asserted-by":"publisher","unstructured":"Vasanthan J, Gurusamy N, Rajasingh S, Sigamani V, Kirankumar S, Thomas EL, et al. Role of human mesenchymal stem cells in regenerative therapy. Cells. 2020;10(1):2073\u20134409. https:\/\/doi.org\/10.3390\/cells10010054.","DOI":"10.3390\/cells10010054"},{"issue":"2","key":"9565_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00266-016-0613-1","volume":"40","author":"NM Toyserkani","year":"2016","unstructured":"Toyserkani NM, Quaade ML, Sorensen JA. Cell-assisted lipotransfer: a systematic review of its efficacy. Aesthet Plast Surg. 2016;40(2):309\u201318.","journal-title":"Aesthet Plast Surg"},{"issue":"1","key":"9565_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0183-8","volume":"7","author":"MO Kilinc","year":"2018","unstructured":"Kilinc MO, Santidrian A, Minev I, Toth R, Draganov D, Nguyen D, et al. The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy. Clin Transl Med. 2018;7(1):5.","journal-title":"Clin Transl Med"},{"issue":"1","key":"9565_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1370-2","volume":"10","author":"C Dessels","year":"2019","unstructured":"Dessels C, Ambele MA, Pepper MS. The effect of medium supplementation and serial passaging on the transcriptome of human adipose-derived stromal cells expanded in vitro. Stem Cell Res Ther. 2019;10(1):253.","journal-title":"Stem Cell Res Ther"},{"issue":"16","key":"9565_CR21","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1016\/j.yexcr.2008.06.018","volume":"314","author":"DC Andersen","year":"2008","unstructured":"Andersen DC, Schroder HD, Jensen CH. Non-cultured adipose-derived CD45- side population cells are enriched for progenitors that give rise to myofibres in vivo. Exp Cell Res. 2008;314(16):2951\u201364.","journal-title":"Exp Cell Res"},{"key":"9565_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ebiom.2016.01.024","volume":"5","author":"MK Haahr","year":"2016","unstructured":"Haahr MK, Jensen CH, Toyserkani NM, Andersen DC, Damkier P, Sorensen JA, et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine. 2016;5:204\u201310.","journal-title":"EBioMedicine"},{"key":"9565_CR23","doi-asserted-by":"crossref","unstructured":"Phinney DG, Galipeau J, Msc Committee Of The International Society Of C, Gene T. Manufacturing mesenchymal stromal cells for clinical applications: a survey of good manufacturing practices at U.S. academic centers. Cytotherapy. 2019;21(7):782\u201392.","DOI":"10.1016\/j.jcyt.2019.04.003"},{"issue":"8","key":"9565_CR24","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/sctm.17-0037","volume":"6","author":"NM Toyserkani","year":"2017","unstructured":"Toyserkani NM, Jensen CH, Andersen DC, Sheikh SP, Sorensen JA. Treatment of breast cancer-related lymphedema with adipose-derived regenerative cells and fat grafts: a feasibility and safety study. Stem Cells Transl Med. 2017;6(8):1666\u201372.","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"9565_CR25","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/sctm.17-0031","volume":"6","author":"NM Toyserkani","year":"2017","unstructured":"Toyserkani NM, Jorgensen MG, Tabatabaeifar S, Jensen CH, Sheikh SP, Sorensen JA. Concise review: a safety assessment of adipose-derived cell therapy in clinical trials: a systematic review of reported adverse events. Stem Cells Transl Med. 2017;6(9):1786\u201394.","journal-title":"Stem Cells Transl Med"},{"key":"9565_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8816737","volume":"2020","author":"F Cheng","year":"2020","unstructured":"Cheng F, Huang Z, Li Z. Efficacy and safety of mesenchymal stem cells in treatment of complex perianal fistulas: a meta-analysis. Stem Cells Int. 2020;2020:8816737.","journal-title":"Stem Cells Int"},{"key":"9565_CR27","unstructured":"Panes J, Garcia-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, et al. Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology. 2018;154(5):1334\u201342 e4."},{"issue":"9","key":"9565_CR28","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1177\/0962280216683570","volume":"27","author":"TR Sullivan","year":"2018","unstructured":"Sullivan TR, White IR, Salter AB, Ryan P, Lee KJ. Should multiple imputation be the method of choice for handling missing data in randomized trials? Stat Methods Med Res. 2018;27(9):2610\u201326.","journal-title":"Stat Methods Med Res"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09565-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09565-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09565-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:37:09Z","timestamp":1773902229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09565-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9565"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09565-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial is registered and approved by the EMA (clinical and ethical). Trial identifier in CTIS is as follows: EU CT 2022-502659-73-01. Registered on 18 November 2023.URL: Search for clinical trials\u2014EMA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable. No personal data will be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"214"}}